People infected with the #Eboa virus
could in the near future gain access
to TKM-Ebola, a drug that's been
held up in Phase I clinical trials by
the US Food & Drug Administration,
Business Insider says.
This came after the FDA modified the
full clinical hold placed on the drug,
which enables it to be administered
to people sick with the virus.
Excerpt:
Here's what management is said in
its 4:45 p.m. ET press release:
"[Tekmira] today announced that the
U.S. Food & Drug Administration
(FDA) has verbally confirmed they
have modified the full clinical hold
placed on the TKM-Ebola
Investigational New Drug Application
(IND) to a partial clinical hold. This
action enables the potential use of
TKM-Ebola in individuals infected
with Ebola virus."
"We are pleased that the FDA has
considered the risk-reward of TKM-
Ebola for infected patients," said
Tekmira CEO Mark Murray. We
have been closely watching the Ebola
virus outbreak and its consequences,
and we are willing to assist with any
responsible use of TKM-Ebola. The
foresight shown by the FDA removes
one potential roadblock to doing so."
No comments:
Post a Comment